Citation Impact
Citing Papers
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Determination of cocaine and selected metabolites in canine and human serum by reversed-phase high-performance liquid chromatography on coupled cyanopropyl and silica columns
1989
Identification of human cytochrome P 450 s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data
2003
Network analysis identifies Rv0324 and Rv0880 as regulators of bedaquiline tolerance in Mycobacterium tuberculosis
2016
Top 10 Challenges in Cancer Immunotherapy
2020
Cardiolipin Is Not Required for Bax-mediated Cytochrome c Release from Yeast Mitochondria
2004
Food proteins: A review on their emulsifying properties using a structure–function approach
2013 Standout
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
2009
Engineering interferons and interleukins for cancer immunotherapy
2022
Pharmacokinetic-Pharmacodynamic and Dose-Response Relationships of Antituberculosis Drugs: Recommendations and Standards for Industry and Academia
2015
Hydrophilic interaction chromatography
2006 Standout
Metabolic Drug Interactions with Newer Antipsychotics: A Comparative Review
2006
Drug discovery considerations in the development of covalent inhibitors
2013
Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase
2014
The Normalcy of Dormancy: Common Themes in Microbial Quiescence
2013
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
The use of spirocyclic scaffolds in drug discovery
2014 Standout
CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6α-hydroxylase activity in human liver microsomes
2002
Antimicrobial resistance: a global multifaceted phenomenon
2015 Standout
Advances in the development of new tuberculosis drugs and treatment regimens
2013
Cyclopropane Modification of Trehalose Dimycolate Drives Granuloma Angiogenesis and Mycobacterial Growth through Vegf Signaling
2018 StandoutNobel
InhibitingMycobacterium tuberculosiswithin and without
2016
Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation
2020 StandoutNobel
Interactions between antiepileptics and second-generation antipsychotics
2012
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Extensively drug-resistant tuberculosis: epidemiology and management
2014
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Generation and Biological Activities of Oxidized Phospholipids
2009
New approaches to antibiotic discovery
2017
Targeting Energy Metabolism in Mycobacterium tuberculosis , a New Paradigm in Antimycobacterial Drug Discovery
2017
CYP2C8 and Antimalaria Drug Efficacy
2007
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Historical Perspective of Traditional Indigenous Medical Practices: The Current Renaissance and Conservation of Herbal Resources
2014 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Cytochrome P450 2C8 Pharmacogenetics: A Review of Clinical Studies
2009
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Preclinical Characterization of the FAAH Inhibitor JNJ-42165279
2015
Investigational Antimicrobial Agents of 2013
2013
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Visualization of mycobacterial membrane dynamics in live cells
2017 StandoutNobel
Simultaneous determination of sulfamethoxazole and trimethoprim in biological fluids for high-throughput analysis: Comparison of HPLC with ultraviolet and tandem mass spectrometric detection
2008
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
Egg‐yolk lipid fractionation and lecithin characterization
2005
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation
2016 StandoutNobel
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
A Fluorogenic Trehalose Probe for Tracking Phagocytosed Mycobacterium tuberculosis
2020 StandoutNobel
Acute Modulation of Mycobacterial Cell Envelope Biogenesis by Front‐Line Tuberculosis Drugs
2018 StandoutNobel
Computational Design of Cyclic Peptide Inhibitors of a Bacterial Membrane Lipoprotein Peptidase
2024 StandoutNobel
A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery
2019 Standout
The Essential Medicinal Chemistry of Curcumin
2017 Standout
Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis
2017
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Works of Helen Winter being referenced
A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non–Small Cell Lung Cancer Based on Early Tumor Kinetics
2018
Interpreting population pharmacokinetic‐pharmacodynamic analyses – a clinical viewpoint
2010
The effect of clarithromycin, fluconazole, and rifabutin on sulfamethoxazole hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283)
2004
Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics
2005
Open‐label steady‐state pharmacokinetic drug interaction study on co‐administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder
2007
Assessment of the pharmacology and tolerability of PF‐04457845, an irreversible inhibitor of fatty acid amide hydrolase‐1, in healthy subjects
2011
Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting
2019
Detection of phospholipid oxidation in oxidatively stressed cells by reversed-phase HPLC coupled with positive-ionization electroscopy MS
2001
The effect of clarithromycin, fluconazole, and rifabutin on dapsone hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283)
2004
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
2012
Determination of Pharmacokinetics of Cocaine in Sheep by Liquid Chromatography
1987
Randomized Dose-Ranging Study of the 14-Day Early Bactericidal Activity of Bedaquiline (TMC207) in Patients with Sputum Microscopy Smear-Positive Pulmonary Tuberculosis
2013
CYP2C8/9 Mediate Dapsone N-Hydroxylation at Clinical Concentrations of Dapsone
2000
Detection of phospholipid oxidation in oxidatively stressed cells by reversed-phase HPLC coupled with positive-ionization electroscopy MS
2001